Effect of zinc oxide nanoparticles on dams and embryo–fetal development in rats

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 145-157

  Hong, Jeong Sup ^a,b   Park, Myeong Kyu ^a   Kim, Min Seok ^a   Lim, Jeong Hyeon ^a   Park, Gil Jong ^a   Maeng, Eun Ho ^a   Shin, Jae Ho ^c   Kim, Yu Ri ^d   Kim, Meyoung Kon ^d   Lee, Jong Kwon ^e   Park, Jin A ^b   Kim, Jong Choon ^f   Shin, Ho Chul ^b  

^a Korea Testing and Research Institute   (South Korea)

^b Konkuk University   (South Korea)

^c Eulji University   (South Korea)

^d Korea University   (South Korea)

^e National Institute of Food and Drug Safety Evaluation   (South Korea)

^f Chonnam National University   (South Korea)

Author keywords

Developmental toxicity; Maternal toxicity; Nanoparticles; Nanotoxicology; Teratogenicity; Zinc oxide

Indexed keywords

ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; ZINC OXIDE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DAM (ANIMAL); EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; FEMALE; FETOTOXICITY; FETUS; FETUS DEATH; FETUS DEVELOPMENT; FETUS WEIGHT; GESTATION PERIOD; LITTER SIZE; LIVER WEIGHT; MALE; MOUSE; NIDATION; NONHUMAN; PLACENTA WEIGHT; PREGNANCY; SEX RATIO; SKELETON; SPRAGUE DAWLEY RAT; VISCERA; WEIGHT REDUCTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; RAT; TOXICITY TESTING;

ANIMALS; FEMALE; FETAL DEVELOPMENT; METAL NANOPARTICLES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS; ZINC OXIDE;

EID: 84947423248     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57931     Document Type: Article

References (68)

1. 2 and ZnO nanoparticles as antiwear additive in oil lubricants. Wear. 2008;265 (3–4):422–428.
2. Schilling K, Bradford B, Castelli D, et al. Human safety review of “nano” titanium dioxide and zinc oxide. Photochem Photobiol Sci. 2010;9(4): 495–509.
3. Gerloff K, Albrecht C, Boots AW, Förster I, Schins RPF. Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology. 2009;3(4):355–364.
4. Jin T, Sun D, Su JY, Zhang H, Sue HJ. Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella Enteritidis, and Escherichia coli O157:H7. J Food Sci. 2009;74(1): M46–M52.
5. He L, Liu Y, Mustapha A, Lin M. Antifungal activity of zinc oxide nanoparticles against Botrytis cinerea and Penicillium expansum. Microbiol Res. 2011;166(3):207–215.
6. Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv. 2010;7(9): 1063–1077.
7. John S, Marpu S, Li J, et al. Hybrid zinc oxide nanoparticles for biophotonics. J Nanosci Nanotechnol. 2010;10(3):1707–1712.
8. Drinker P, Thomson RM, Finn JL. Metal fume fever: IV. Threshold doses of zinc oxide, preventative measures, and the chronic effects of repeated exposures. J Ind Hyg Toxicol. 1927;9:331–345.
9. Blanc P, Wong H, Bernstein MS, Boushey HA. An experimental human model of metal fume fever. Ann Intern Med. 1991;114(11):930–936.
10. Baek M, Chung HE, Yu J, et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine. 2012;7: 3081–3097.
11. Vaseem M, Umar A, Hahn YB. ZnO nanoparticles: growth, properties, and applications. In: Umar A, Hahn YB, editors. Metal Oxide Nanostructures and Their Applications. Valencia, CA: American Scientific Publishers; 2010:1–36.
12. Yah CS, Simate GS, Iyuke SE. Nanoparticles toxicity and their routes of exposures. Pak J Pharm Sci. 2012;25(2):477–491.
13. Wang L, Wang L, Ding W, Zhang F. Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats. J Nanosci Nanotechnol. 2010;10(12): 8617–8624.
14. Wang J, Zhou G, Chen C, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett. 2007;168(2):176–185.
15. Wang B, Feng W, Wang M, et al. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res. 2008;10:263–276.
16. Surekha P, Kishore AS, Srinivas A, et al. Repeated dose dermal toxicity study of nano zinc oxide with Sprague-Dawley rats. Cutan Ocul Toxicol. 2012;31(1):26–32.
17. Yan G, Huang Y, Bu Q, et al. Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2012;47(4):577–588.
18. Lu X, Liu Y, Kong X, Lobie PE, Chen C, Zhu T. Nanotoxicity: a growing need for study in the endocrine system. Small. 2013;9(9–10): 1654–1671.
19. Iavicoli I, Fontana L, Leso V, Bergamaschi A. The effects of nanomaterials as endocrine disruptors. Int J Mol Sci. 2013;14(8):16732–16801.
20. Yamashita K, Yoshioka Y. [Safety assessment of nanomaterials in reproductive developmental field]. Yakugaku Zasshi. 2012;132(3):331–335. Japanese.
21. The Organization for Economic Cooperation and Development [webpage on the Internet]. Test no. 414: prenatal development toxicity study. Paris, France: The Organization for Economic Cooperation and Development; 2001. Available from: http://www.oecd-ilibrary.org/environment/test-no-414-prenatal-development-toxicity-study_9789264070820-en. Accessed November 26, 2014.
22. The Organization for Economic Cooperation and Development. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. Number 1. OECD Principles on Good Laboratory Practice (As Revised in 1997). Paris, France: The Organization for Economic Cooperation and Development; 1998. Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/mc/chem(98)17&doclanguage=en. Accessed November 26, 2014.
23. KFDA. GLP principle of Korea Food and Drug Administration KFDA Gosi 2009-183. KFDA. Ministry of Food and Drug Safety. Korea.
24. Degen A, Kosec M. Effect of pH and impurities on the surface charge of zinc oxide in aqueous solution. J Eur Ceram Soc. 2000;20(6): 667–673.
25. Oh JM, Park DH, Choy JH. Integrated bio-inorganic hybrid systems for nano-forensics. Chem Soc Rev. 2011;40(2):583–595.
26. Kim KM, Kim TH, Kim HM, et al. Colloidal behaviors of ZnO nanoparticles in various aqueous media. Toxicology and Environmental Health Sciences. 2012;4(2):121–131.
27. Chung HE, Yu J, Baek M, et al. Toxicokinetics of zinc oxide nanoparticles in rats. J Phys Conf Ser. 2013:429.
28. Yamada T, Hara M, Ohba Y, Inoue T, Ohno H. [Studies on implantation traces in rats. II. Staining of cleared uteri, formation and distribution of implantation traces]. Jikken Dobutsu. 1985;34(3):249–260. Japanese.
29. Menegola E, Broccia ML, Giavini E. Atlas of rat fetal skeleton double stained for bone and cartilage. Teratology. 2001;64(3):125–133.
30. Wilson JG. Methods for administering agents and detecting malformations in experimental animals. In: Wilson JG, Warkany J, editors. Teratology, Principles and Techniques. Chicago, IL: University of Chicago Press; 1965:262–277.
31. Nishimura K. A microdissection method for detecting thoracic visceral malformations in mouse and rat fetuses. Congenit Anom (Kyoto). 1974;14:23–40.
32. Chahoud I, Buschmann J, Clark R, et al. Classification terms in developmental toxicology: need for harmonisation. Report of the Second Workshop on the Terminology in Developmental Toxicology Berlin, 27–28 August 1998. Reprod Toxicol. 1999;13(1):77–82.
33. Makris SL, Solomon HM, Clark R, et al. Terminology of developmental abnormalities in common laboratory mammals (version 2). Congenit Anom (Kyoto). 2009;49(3):123–246.
34. Weil CS. Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis or carcinogenesis. Food Cosmet Toxicol. 1970;8(2):177–182.
35. Scheffé H. A method for judging all contrasts in the analysis of variance*. Biometrika. 1953;40(1/2):87–110.
36. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47(260):583–621.
37. Fisher RA. Statistical Methods for Research Workers. 14th ed. Edinburgh, Scotland: Oliver and Boyd; 1970.
38. Bryant PL, Schmid JE, Fenton SE, Buckalew AR, Abbott BD. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha. Toxicol Sci. 2001;62(1):103–114.
39. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res. 2012;745(1–2): 84–91.
40. Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol. 2013;35(1):67–71.
41. Miller RJ, Lenihan HS, Muller EB, Tseng N, Hanna SK, Keller AA. Impacts of metal oxide nanoparticles on marine phytoplankton. Environ Sci Technol. 2010;44(19):7329–7334.
42. Sinha R, Karan R, Sinha A, Khare SK. Interaction and nanotoxic effect of ZnO and Ag nanoparticles on mesophilic and halophilic bacterial cells. Bioresour Technol. 2011;102(2):1516–1520.
43. Wang HJ, Growcock AC, Tang TH, O’Hara J, Huang YW, Aronstam RS. Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signaling pathway. Toxicol In Vitro. 2010;24(7):1953–1961.
44. Shulin JI, Changhui YE. Synthesis, growth mechanism, and applications of zinc oxide nanomaterials. Journals of Materials Science and Technology. 2008;24(4):457–472.
45. Wang JL. Zinc oxide nanostructures: growth, properties and applications. J Phys Condens Matter. 2004;16:R829–R858.
46. Ajayan M, Zhou OZ. Applications of carbon nanotubes. Carbon Nanotubes: Topics in Applied Physics. 2001;80:391–425.
47. Leeuwenburgh SC, Ana ID, Jansen JA. Sodium citrate as an effective dispersant for the synthesis of inorganic-organic composites with a nanodispersed mineral phase. Acta Biomater. 2010;6(3):836–844.
48. Parkinson JA, Sun H. New approach to the solution chemistry of bismuth citrate antiulcer complexes. Chem Commun (Camb). 1998;(8): 881–882.
49. Andersen H, Larsen S, Spliid H, Christensen ND. Multivariate statistical analysis of organ weights in toxicity studies. Toxicology. 1999;136 (2–3):67–77.
50. Bailey SA, Zidell RH, Perry RW. Relationships between organ weight and body/brain weight in the rat: what is the best analytical endpoint? Toxicol Pathol. 2004;32(4):448–466.
51. Chung MK, Kim CY, Kim JC. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring. Cancer Chemother Pharmacol. 2007;59(3):383–395.
52. Chen Z, Meng H, Xing G, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006;163(2):109–120.
53. Cui Y, Liu H, Zhou M, et al. Signaling pathway of inflammatory responses in the mouse liver caused by TiO2 nanoparticles. J Biomed Mater Res A. 2011;96(1):221–229.
54. Odio MR, Maickel RP. Comparative biochemical responses of rats to different stressful stimuli. Physiol Behav. 1985;34(4):595–599.
55. Kioukia-Fougia N, Antoniou K, Bekris S, Liapi C, Christofidis I, Papadopoulou-Daifoti Z. The effects of stress exposure on the hypothalamic-pituitary-adrenal axis, thymus, thyroid hormones and glucose levels. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(5): 823–830.
56. Kim HY, Lee SB, Chung YH, et al. Evaluation of subchronic inhalation toxicity of dimethyl disulfide in rats. Inhal Toxicol. 2006;18(5): 395–403.
57. Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291(5):E965–E973.
58. Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29(1):69–78.
59. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2(10):2121–2134.
60. Huang Z, Zheng X, Yan D, et al. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir. 2008;24(8):4140–4144.
61. Ma H, Bertsch PM, Glenn TC, Kabengi NJ, Williams PL. Toxicity of manufactured zinc oxide nanoparticles in the nematode Caenorhabditis elegans. Environ Toxicol Chem. 2009;28(6):1324–1330.
62. Franklin NM, Rogers NJ, Apte SC, Batley GE, Gadd GE, Casey PS. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ Sci Technol. 2007;41(24): 8484–8490.
63. Morita H, Ariyuki F, Inomata N, et al. Spontaneous malformations in laboratory animals: frequency of external, internal and skeletal malformations in rats, rabbits and mice*. Congenit Anom (Kyoto). 1987;27(2):147–206.
64. Hood RD. Handbook of Developmental Toxicology. New York, NY: Informa Healthcare; 1997.
65. Kim JC, Lee SJ, Bae JS, Park JI, Kim YB, Chung MK. Historical control data for developmental toxicity study in Sprage-Dawley rats. J Toxicol Public Health. 2001;17:83–90. Korean.
66. Yamashita K, Yoshioka Y, Higashisaka K, et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol. 2011;6(5):321–328.
67. Durnev AD, Solomina AS, Daugel-Dauge NO, et al. Evaluation of genotoxicity and reproductive toxicity of silicon nanocrystals. Bull Exp Biol Med. 2010;149(4):445–449.
68. Hong JS, Kim S, Lee SH, et al. Combined repeated-dose toxicity study of silver nanoparticles with the reproduction/developmental toxicity screening test. Nanotoxicology. 2014;8(4):349–362.